A phase 2 trial of fludarabine combined with subcutaneous alemtuzumab for the treatment of relapsed/refractory B-cell chronic lymphocytic leukemia

Christopher R. Flowers, Jennifer R. Brown, Hilary Rosenthal, Wendy Stock, Harvey I. Katzen, Jonathon B. Cohen, Rajni Sinha, Shailendra Lakhanpal, Jose F. Leis, Edmund K. Waller, David L. Jaye

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of fludarabine combined with subcutaneous alemtuzumab for the treatment of relapsed/refractory B-cell chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences